Apel Daniel Joseph — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Apel Daniel Joseph has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $934K.

Profile

Apel Daniel Joseph

Daniel Joseph Apel is the Chief Financial Officer at Arrowhead Pharmaceuticals, Inc., a biotechnology company focused on developing medicines that treat intractable diseases by silencing genes. He has a background in finance and corporate management, contributing to the financial strategies and operations of the company.

RoleChief Financial Officer
Notability10/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-04-24ARWRARROWHEAD PHARMACEUTICALS, INC.S — Open-market sale8.7K$71.92$628K
2026-04-24ARWRARROWHEAD PHARMACEUTICALS, INC.S — Open-market sale1.2K$70.45$82K
2026-04-24ARWRARROWHEAD PHARMACEUTICALS, INC.S — Open-market sale3.2K$70.11$225K

Companies — Last 90 Days

Frequently Asked Questions

Who is Apel Daniel Joseph?

Daniel Joseph Apel is the Chief Financial Officer at Arrowhead Pharmaceuticals, Inc., a biotechnology company focused on developing medicines that treat intractable diseases by silencing genes. He has a background in finance and corporate management, contributing to the financial strategies and operations of the company.…

How many SEC Form 4 filings has Apel Daniel Joseph submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Apel Daniel Joseph been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($934K) across all tracked filings.

Where can I see all of Apel Daniel Joseph's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Apel Daniel Joseph profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.